Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the opening of its new Regional HQ office in San Diego and the appointment of Joel Centeno as VP regulatory and quality.
Joel Centeno joins Enigma as VP regulatory and quality, US and will be responsible for obtaining appropriate regulatory approval for Enigma’s rapid diagnostic instrument systems and products. Joel brings extensive executive experience in quality system design and implementation, new product development in molecular diagnostics and clinical trial expertise.
Before joining the Enigma team, Joel served as Director, QA/RA at Hologic Inc where in addition to leading global quality and regulatory activities for the Molecular Diagnostic Division, he also obtained FDA approval on products including Cervista HPV and Inplex cystic fibrosis IVD tests. Joel received his BS in Materials Engineering and Metallurgy from the University of Florida in 1999.
Source: Enigma Diagnostics
